Rxo earnings were -$21.0M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest RXO earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$7.0M, down 53.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RXO reported annual earnings of $4.0M, with -95.7% growth. The next RXO earnings date is Nov 7, 2024.
On RXO's earnings call on Invalid Date, Rxo (NYSE: RXO) reported Q2 2024 earnings per share (EPS) of -$0.06, up 300% year over year. Total RXO earnings for the quarter were -$7.00 million. In the same quarter last year, Rxo's earnings per share (EPS) was $0.03.
The next RXO earnings call is Invalid Date. Add RXO to your watchlist to be reminded of Rxo's next earnings date.
Is Rxo profitable or losing money?
As of the last Rxo earnings report, Rxo is currently losing money. Rxo's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$21.00 million, a 275% decrease year over year.
What was RXO's earnings growth in the past year?
As of Rxo's earnings date in Invalid Date, Rxo's earnings has grown year over year. RXO earnings in the past year totalled -$21.00 million.
What are Rxo's earnings expectations?
The current EPS estimate for Rxo's earnings report in Invalid Date is $0.04.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.